Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-04 12:05 pm Purchase | 13G | JASPER THERAPEUTICS INC NE JSPR | SPHERA FUNDS MANAGEMENT LTD. | 189,270 1.250% | 189,270 (New Position) | View |
| 2024-08-20 2:36 pm Purchase | 13G | CHEMOMAB THERAPEUTICS LTD CMMB | SPHERA FUNDS MANAGEMENT LTD. | 1,214,575 6.560% | 1,214,575 (New Position) | View |
| 2024-02-08 09:51 am Purchase | 13G | Skye Bioscience Inc. SKYE | SPHERA FUNDS MANAGEMENT LTD. | 1,301,518 5.390% | 1,301,518 (New Position) | View |
| 2024-02-05 09:15 am Purchase | 13G | JASPER THERAPEUTICS INC NE JSPR | SPHERA FUNDS MANAGEMENT LTD. | 7,130,625 6.390% | 1,443,491 (+25.38%) | View |
| 2024-02-05 09:13 am Sale | 13G | Praxis Precision Medicines Inc. PRAX | SPHERA FUNDS MANAGEMENT LTD. | 328,986 3.740% | -8,435,348 (-96.25%) | View |
| 2024-02-05 09:12 am Sale | 13G | INOZYME PHARMA INC INZY | SPHERA FUNDS MANAGEMENT LTD. | 1,562,907 2.530% | -533,351 (-25.44%) | View |
| 2024-02-05 09:10 am Purchase | 13G | ProMIS Neurosciences Inc. PMN | SPHERA FUNDS MANAGEMENT LTD. | 1,892,474 9.990% | 39,956 (+2.16%) | View |
| 2023-10-10 11:15 am Purchase | 13G | JASPER THERAPEUTICS INC NE JSPR | SPHERA FUNDS MANAGEMENT LTD. | 5,687,134 5.130% | 5,687,134 (New Position) | View |
| 2023-08-30 09:43 am Purchase | 13G | ProMIS Neurosciences Inc. PMN | SPHERA FUNDS MANAGEMENT LTD. | 1,852,518 9.990% | 1,852,518 (New Position) | View |
| 2023-06-27 10:01 am Unchanged | 13G | Praxis Precision Medicines Inc. PRAX | SPHERA FUNDS MANAGEMENT LTD. | 8,764,334 7.350% | 0 (Unchanged) | View |
| 2023-06-22 11:26 am Purchase | 13G | Praxis Precision Medicines Inc. PRAX | SPHERA FUNDS MANAGEMENT LTD. | 8,764,334 7.310% | 8,764,334 (New Position) | View |
| 2023-03-07 06:01 am Purchase | 13G | INOZYME PHARMA INC INZY | SPHERA FUNDS MANAGEMENT LTD. | 2,096,258 5.190% | 2,096,258 (New Position) | View |
| 2023-02-06 11:27 am Sale | 13G | CYCLACEL PHARMACEUTICALS INC C CYCC | SPHERA FUNDS MANAGEMENT LTD. | 250,000 1.990% | -258,322 (-50.82%) | View |
| 2022-02-14 06:15 am Purchase | 13G | CYCLACEL PHARMACEUTICALS INC C CYCC | SPHERA FUNDS MANAGEMENT LTD. | 508,322 5.100% | 1,498 (+0.30%) | View |
| 2022-02-14 06:13 am Sale | 13G | Altimmune Inc. ALT | SPHERA FUNDS MANAGEMENT LTD. | 1,244,241 3.130% | -2,531,377 (-67.05%) | View |
| 2021-08-31 11:03 am Purchase | 13G | Altimmune Inc. ALT | SPHERA FUNDS MANAGEMENT LTD. | 3,775,618 8.840% | 3,775,618 (New Position) | View |
| 2021-03-18 12:59 pm Purchase | 13G | CYCLACEL PHARMACEUTICALS INC C CYCC | SPHERA FUNDS MANAGEMENT LTD. | 506,824 6.290% | 506,824 (New Position) | View |
| 2021-02-16 09:04 am Sale | 13G | Orgenesis Inc. ORGS | SPHERA FUNDS MANAGEMENT LTD. | 525,216 2.130% | -597,874 (-53.23%) | View |
| 2021-02-16 09:00 am Unchanged | 13G | SIO GENE THERAPIES INC SIOX | SPHERA FUNDS MANAGEMENT LTD. | 0 0.000% | 0 (Unchanged) | View |
| 2021-02-16 08:57 am Unchanged | 13G | LARIMAR THERAPEUTICS INC LRMR | SPHERA FUNDS MANAGEMENT LTD. | 0 0.000% | 0 (Unchanged) | View |